USCOM (ASX:UCM) Receivables Turnover : 5.12 (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is USCOM Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. USCOM's Revenue for the six months ended in Dec. 2023 was A$1.71 Mil. USCOM's average Accounts Receivable for the six months ended in Dec. 2023 was A$0.33 Mil. Hence, USCOM's Receivables Turnover for the six months ended in Dec. 2023 was 5.12.

USCOM Receivables Turnover Historical Data

The historical data trend for USCOM's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

USCOM Receivables Turnover Chart

USCOM Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Receivables Turnover

Get a 7-Day Free Trial

6.84

8.14

15.53

11.26

15.01

USCOM Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Receivables Turnover	Get a 7-Day Free Trial															4.19	5.41	3.03	5.59	5.12

Competitive Comparison of USCOM's Receivables Turnover

For the Medical Devices subindustry, USCOM's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

USCOM's Receivables Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, USCOM's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where USCOM's Receivables Turnover falls into.

USCOM Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

USCOM's Receivables Turnover for the fiscal year that ended in Jun. 2023 is calculated as

	Receivables Turnover (A: Jun. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Jun. 2023 )	/ (	(Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )
=	2.664	/ (	(0.221	+	0.134)	/	2 )
=	2.664	/	0.1775
=	15.01

USCOM's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

	Receivables Turnover (Q: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2023 )	/ (	(Accounts Receivable (Q: Jun. 2023 )	+	Accounts Receivable (Q: Dec. 2023 ))	/	count )
=	1.709	/ (	(0.134	+	0.534)	/	2 )
=	1.709	/	0.334
=	5.12

USCOM (ASX:UCM) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

USCOM Receivables Turnover Related Terms

Thank you for viewing the detailed overview of USCOM's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

USCOM (ASX:UCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » USCOM Ltd (ASX:UCM) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 8, 66 Clarence Street, Suite 2, Sydney, NSW, AUS, 2000

Website

https://www.uscom.com.au

USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. It generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology and the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimizing respiratory device performance.

USCOM (ASX:UCM) Headlines

No Headlines